Journal of Immunology Research

Pathogenesis and Host Immune Response of Human Polyomaviruses Infection


Publishing date
24 May 2013
Status
Closed
Submission deadline
04 Jan 2013

1Department of Biomedical, Surgical and Odontoiatric Sciences, The University of Milan, Milan, Italy

2Health Science Foundation; Department of Biomedical, Surgical and Odontoiatric Sciences, The University of Milan, Milan, Italy

3Department of Neuroscience, Center for Neurovirology and Comprehensive NeuroAIDS Center, Temple University, Philadelphia, PA, USA

4Division of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan

This issue is now closed for submissions.
More articles will be published in the near future.

Pathogenesis and Host Immune Response of Human Polyomaviruses Infection

This issue is now closed for submissions.
More articles will be published in the near future.

Description

The polyomaviruses are small DNA viruses that can establish latency in the human host. The name polyomavirus is derived from the Greek roots poly-, which means “many,”� and -oma, which means “tumours.”� These viruses were originally isolated in mouse (mPyV) and in monkey (SV40). In 1971, the first human polyomaviruses BK and JC were isolated and subsequently demonstrated to be ubiquitous in the human population. From 2007 and 2012, at least eight other members of the Polyomaviridae family have been identified: KI polyomavirus (KIV), WU polyomavirus (WUV), Merkel cell polyomavirus (MCPyV), Human Polyomavirus 6 and 7 (HPyV6, HPyV7), the Trichodysplasia Spinulosa-associated Virus (TSPyV), the Human Polyomavirus 9 (HPyV9), and, finally, the MW polyomavirus (MWPyV). While some of them are playing an etiological role in known disorders and malignancies in immunosuppressed patients, no specific human diseases have been associated to the infections of the others.

The recent identification of many components of the Polyomaviridae family that are able to infect humans represents a strong incentive for the scientific community to improve and increase the research on the potentialities of these viruses. Moreover, the ubiquity and persistent nature of polyomaviruses make them very challenging in order to define the mechanisms of their pathogenicity.

We invite investigators to contribute original research articles as well as review articles that will improve the knowledge about these viruses, their mechanisms of pathogenicity, their interaction with the host and with the immune system, the classical and the more innovative molecular diagnosis, and the therapeutic approach. Potential topics include, but are not limited to:

  • Elucidating the role of host factors in the development of cellular immunity
  • Elucidating the role of host factors in the development of innate immunity
  • Impact of immunosuppressive agents on virus-specific immune response
  • Identifying key immune factors that differentiate the latent viral status from the lytic viral status
  • Cellular and animal models to test the interaction between polyomaviruses and the host
  • The influence of coinfection with other infectious agents, such as HIV-1, on polyomaviruses immunity
  • Development of immunotherapeutic strategies to treat polyomaviruses infection
  • Immunity of the polyomaviruses-associated tumors

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jir/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/jir/hpih/ according to the following timetable:

Journal of Immunology Research
 Journal metrics
Acceptance rate40%
Submission to final decision65 days
Acceptance to publication30 days
CiteScore3.330
Impact Factor3.404
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.